The Report Includes:
- An overview of recent advances in stem cell therapies and coverage of potential stem cells used for regenerative advanced therapies
- Discussion on role of genomic and epigenomics manipulations in generating safe and effective treatment options
- Identification of autologous and allogeneic cells and their usage in creating advanced therapy medical products (ATMPs)
- Information on 3D cell culture and discussion on advances in gene editing and gene programming techniques such as CRIPSR/Cas9, TALEN, and ZINC fingers
- Insights into commercial and regulatory landscape, and evaluation of challenges and opportunities for developing autologous and allogenic “off the shelf” solutions
Table of Contents
Chapter 1 Sources and Characteristics of Stem Cells
Chapter 2 New Technologies Driving Stem Cell Development
Chapter 3 Safety, Efficacy and Logistical Challenges
Chapter 4 Off-the-Shelf Solutions
Chapter 5 Companies and Technologies to Watch
List of Tables
List of Figures
Companies Mentioned
- Athersys Inc.
- Brainstorm Cell Therapeutics Inc.
- Caladrius Biosciences
- Cellular Biomedicine Group Inc.
- Fate Therapeutics Inc.
- Gamida Cell Ltd.
- International Stem Cell Corporation
- Orgenesis Inc.
- Pluristem Therapeutics Inc.
- Sangamo Therapeutics Inc.
- Theracell Inc.
- Thermogenesis Holdings
- Vericel Corporation
- Vistagen Therapeutics Inc.
- Zelluna Immunotherapy Inc.